Beattie D T, Smith J A M
Pharmacology Department, Theravance, Inc, 901 Gateway Boulevard, South San Francisco, CA 94080, USA.
Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):181-203. doi: 10.1007/s00210-008-0276-9. Epub 2008 Apr 9.
Serotonin (5-hydroxytryptamine or 5-HT) plays a critical physiological role in the regulation of gastrointestinal (GI) function. 5-HT dysfunction may also be involved in the pathophysiology of a number of functional GI disorders, such as chronic constipation, irritable bowel syndrome and functional dyspepsia. This article describes the role of 5-HT in the enteric nervous system (ENS) of the mammalian GI tract and the receptors with which it interacts. Existing serotonergic therapies that have proven effective in the treatment of GI functional disorders and the potential of drugs currently in development are also highlighted. Advances in our understanding of the physiological and pathophysiological roles of 5-HT in the ENS and the identification of selective receptor ligands bodes well for the future development of more efficacious therapies for patients with functional GI disorders.
血清素(5-羟色胺或5-羟色氨酸)在胃肠道(GI)功能调节中发挥着关键的生理作用。5-羟色胺功能障碍也可能参与多种功能性胃肠疾病的病理生理过程,如慢性便秘、肠易激综合征和功能性消化不良。本文描述了5-羟色胺在哺乳动物胃肠道肠神经系统(ENS)中的作用及其相互作用的受体。还强调了已被证明对治疗胃肠功能障碍有效的现有5-羟色胺能疗法以及目前正在研发的药物的潜力。我们对5-羟色胺在肠神经系统中的生理和病理生理作用的理解取得进展,以及选择性受体配体的鉴定,为未来开发更有效的功能性胃肠疾病治疗方法带来了良好前景。